The central vein sign in multiple sclerosis: a biomarker evaluated on a 3T MRI scanner

Detalhes bibliográficos
Autor(a) principal: Campos, Lillian Goncalves
Data de Publicação: 2021
Outros Autores: Arruda, Bruna Da Silveira, Viuniski, Verena Subtil, Londero, Renata, Finkelsztejn, Alessandro, Duarte, Juliana Ávila
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Clinical and Biomedical Research
Texto Completo: https://seer.ufrgs.br/index.php/hcpa/article/view/103611
Resumo: The central vein sign (CVS) is a promising MRI biomarker in multiple sclerosis (MS). CVS has recently been proposed to improve the accuracy and speed of MS diagnosis. Evidence indicates that the presence of CVS in individual lesions can accurately differentiate MS from other diseases that mimic this condition, such as hypertensive microangiopathy, atypical demyelination, and neuromyelitis optica. Most studies have used 7T MRI scanners, which limits their clinical applicability. Recently, it has been demonstrated that the fusion of the FLAIR and SWI sequences, generating FLAIR*, allows CVS visualization even on 3T scanners. Many studies have confirmed that CVS at 3T is a specific imaging finding for MS.
id UFRGS-20_bc9a096bb47c761f51b94d4e632ece0b
oai_identifier_str oai:seer.ufrgs.br:article/103611
network_acronym_str UFRGS-20
network_name_str Clinical and Biomedical Research
repository_id_str
spelling The central vein sign in multiple sclerosis: a biomarker evaluated on a 3T MRI scannerMultiple sclerosiscentral vein signdemyelinating diseaseNeuroradiologyThe central vein sign (CVS) is a promising MRI biomarker in multiple sclerosis (MS). CVS has recently been proposed to improve the accuracy and speed of MS diagnosis. Evidence indicates that the presence of CVS in individual lesions can accurately differentiate MS from other diseases that mimic this condition, such as hypertensive microangiopathy, atypical demyelination, and neuromyelitis optica. Most studies have used 7T MRI scanners, which limits their clinical applicability. Recently, it has been demonstrated that the fusion of the FLAIR and SWI sequences, generating FLAIR*, allows CVS visualization even on 3T scanners. Many studies have confirmed that CVS at 3T is a specific imaging finding for MS.HCPA/FAMED/UFRGS2021-02-03info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionArtigo avaliado por paresapplication/pdfhttps://seer.ufrgs.br/index.php/hcpa/article/view/103611Clinical & Biomedical Research; Vol. 40 No. 2 (2020): Clinical and Biomedical ResearchClinical and Biomedical Research; v. 40 n. 2 (2020): Clinical and Biomedical Research2357-9730reponame:Clinical and Biomedical Researchinstname:Universidade Federal do Rio Grande do Sul (UFRGS)instacron:UFRGSenghttps://seer.ufrgs.br/index.php/hcpa/article/view/103611/pdfCopyright (c) 2021 Clinical and Biomedical Researchinfo:eu-repo/semantics/openAccessCampos, Lillian GoncalvesArruda, Bruna Da SilveiraViuniski, Verena SubtilLondero, RenataFinkelsztejn, AlessandroDuarte, Juliana Ávila2024-01-19T14:21:14Zoai:seer.ufrgs.br:article/103611Revistahttps://www.seer.ufrgs.br/index.php/hcpaPUBhttps://seer.ufrgs.br/index.php/hcpa/oai||cbr@hcpa.edu.br2357-97302357-9730opendoar:2024-01-19T14:21:14Clinical and Biomedical Research - Universidade Federal do Rio Grande do Sul (UFRGS)false
dc.title.none.fl_str_mv The central vein sign in multiple sclerosis: a biomarker evaluated on a 3T MRI scanner
title The central vein sign in multiple sclerosis: a biomarker evaluated on a 3T MRI scanner
spellingShingle The central vein sign in multiple sclerosis: a biomarker evaluated on a 3T MRI scanner
Campos, Lillian Goncalves
Multiple sclerosis
central vein sign
demyelinating disease
Neuroradiology
title_short The central vein sign in multiple sclerosis: a biomarker evaluated on a 3T MRI scanner
title_full The central vein sign in multiple sclerosis: a biomarker evaluated on a 3T MRI scanner
title_fullStr The central vein sign in multiple sclerosis: a biomarker evaluated on a 3T MRI scanner
title_full_unstemmed The central vein sign in multiple sclerosis: a biomarker evaluated on a 3T MRI scanner
title_sort The central vein sign in multiple sclerosis: a biomarker evaluated on a 3T MRI scanner
author Campos, Lillian Goncalves
author_facet Campos, Lillian Goncalves
Arruda, Bruna Da Silveira
Viuniski, Verena Subtil
Londero, Renata
Finkelsztejn, Alessandro
Duarte, Juliana Ávila
author_role author
author2 Arruda, Bruna Da Silveira
Viuniski, Verena Subtil
Londero, Renata
Finkelsztejn, Alessandro
Duarte, Juliana Ávila
author2_role author
author
author
author
author
dc.contributor.author.fl_str_mv Campos, Lillian Goncalves
Arruda, Bruna Da Silveira
Viuniski, Verena Subtil
Londero, Renata
Finkelsztejn, Alessandro
Duarte, Juliana Ávila
dc.subject.por.fl_str_mv Multiple sclerosis
central vein sign
demyelinating disease
Neuroradiology
topic Multiple sclerosis
central vein sign
demyelinating disease
Neuroradiology
description The central vein sign (CVS) is a promising MRI biomarker in multiple sclerosis (MS). CVS has recently been proposed to improve the accuracy and speed of MS diagnosis. Evidence indicates that the presence of CVS in individual lesions can accurately differentiate MS from other diseases that mimic this condition, such as hypertensive microangiopathy, atypical demyelination, and neuromyelitis optica. Most studies have used 7T MRI scanners, which limits their clinical applicability. Recently, it has been demonstrated that the fusion of the FLAIR and SWI sequences, generating FLAIR*, allows CVS visualization even on 3T scanners. Many studies have confirmed that CVS at 3T is a specific imaging finding for MS.
publishDate 2021
dc.date.none.fl_str_mv 2021-02-03
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
Artigo avaliado por pares
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://seer.ufrgs.br/index.php/hcpa/article/view/103611
url https://seer.ufrgs.br/index.php/hcpa/article/view/103611
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://seer.ufrgs.br/index.php/hcpa/article/view/103611/pdf
dc.rights.driver.fl_str_mv Copyright (c) 2021 Clinical and Biomedical Research
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2021 Clinical and Biomedical Research
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv HCPA/FAMED/UFRGS
publisher.none.fl_str_mv HCPA/FAMED/UFRGS
dc.source.none.fl_str_mv Clinical & Biomedical Research; Vol. 40 No. 2 (2020): Clinical and Biomedical Research
Clinical and Biomedical Research; v. 40 n. 2 (2020): Clinical and Biomedical Research
2357-9730
reponame:Clinical and Biomedical Research
instname:Universidade Federal do Rio Grande do Sul (UFRGS)
instacron:UFRGS
instname_str Universidade Federal do Rio Grande do Sul (UFRGS)
instacron_str UFRGS
institution UFRGS
reponame_str Clinical and Biomedical Research
collection Clinical and Biomedical Research
repository.name.fl_str_mv Clinical and Biomedical Research - Universidade Federal do Rio Grande do Sul (UFRGS)
repository.mail.fl_str_mv ||cbr@hcpa.edu.br
_version_ 1799767055716581376

Registros relacionados